Like Radiation Simulation Software

closed 8/5/2014 via PR Newswire

Varian Medical Systems, Inc., purchased Radiation Simulation Software from Transpire, Inc.

synopsis: Varian Medical Systems, Inc., announced it has acquired certain assets of Transpire, Inc., including the Acuros® dose calculation software that has been integrated into Varian's market-leading BrachyVision™ and Eclipse™ treatment planning software products. The acquisition also covers Transpire's Attila™ software.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. "
seller: Transpire, Inc.
Transpire develops advanced simulation software products that accurately and rapidly predict the macroscopic behavior of radiation. Their software includes the Attila™ software, used in industries where radiation effects play a role in product performance, and the Acuros® dose calculation software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via PE Hub

Imagia, acquired Cadens Medical Imaging

synopsis: Imagia, a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems, announced the completion of its acquisition of Cadens Medical Imaging (Cadens), a technology leader in medical imaging software.
buyer: Imagia
Imagia is a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems. "
target: Cadens Medical Imaging
Cadens Medical Imaging (Cadens) is a technology leader in medical imaging software. Since 2008, Cadens has developed and marketed FDA and CE cleared innovative medical imaging software products for cancer care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

Ziehm Imaging, acquired THERENVA

synopsis: Germany-based Ziehm Imaging, a developer of mobile X-ray imaging solutions, has acquired Therenva, a leading French developer of planning and imaging software tools for cardiovascular procedures. Ziehm Imaging will leverage its strong distribution network of mobile C-arms to market Therenva’s current product portfolio globally.
buyer: Ziehm Imaging
Germany-based Ziehm Imaging specializes in the development, manufacturing, and worldwide marketing of mobile X-ray-based imaging solutions. The company is the recognized innovation leader in the mobile C-arm industry and a market leader in Germany and other European countries. "
target: THERENVA
France-based Therenva designs the most advanced and user-friendly imaging software toolset for cardiovascular procedures. The unique EndoSize 3D case planning software has become an essential tool in the daily practice of many physicians and healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

MicroSurgical Technology, Inc., acquired Neomedix Corporation

synopsis: In a move to expand its offerings into surgical glaucoma, MST has acquired the assets of NeoMedix Corporation related to glaucoma, including Trabectome and Goniotome product platforms. Trabectome is an easy to use surgical technology used to treat glaucoma, and Goniotome is an innovative solution for goniotomy
buyer parent: Halma plc
buyer: MicroSurgical Technology, Inc.
MicroSurgical Technology (MST) manufactures ophthalmic surgical products, focusing on single-use devices used in cataract surgery. MST makes precise, small tools that allow the management of delicate eye tissue or fluid. "
target: Neomedix Corporation
NeoMedix Corporation develops software and is known for its Trabectome and Goniotome products. Trabectome is an easy to use surgical technology with a clinical history of proven efficacy used to treat glaucoma. Goniotome is an easy and innovative solution for goniotomy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2014 via Company Press Release

Materialise Dental N.V., acquired OrthoView

synopsis: Materialise announced the acquisition of UK-based OrthoView Holdings Limited, the world's leading provider of 2D digital pre-operative planning and templating solutions for orthopedic surgeons. OrthoView’s software imports a digital X-ray image from a PACS and positions the templates of suitable prostheses on the X-ray image at the correct scale.
buyer: Materialise Dental N.V. (GS:MTLS:$86.16)
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis. "
target: OrthoView
OrthoView enables orthopedists to create detailed pre-operative plans quickly and easily from digital x-ray images. The OrthoView solution provides an easy to use method of planning and templating with digital x-ray images, incorporating specialist on-screen measuring tools and patented wizards.
price ($mm)
$14
rev ($mm)
$6
EBITDA ($mm)
$2
EV / rev
2.6x
EV / EBITDA
9.3x
closed 7/3/2019 via BNC Analysis

Surgical Science, acquired SenseGraphics

synopsis: Surgical Science Sweden AB, a Swedish supplier of virtual reality simulators for medical training, has acquired SenseGraphics AB, a Sweden-based medical simulator software developer. SenseGraphics develops medical simulators that combine the latest technologies to provide surgeons with an experience that is as close to reality as possible.
buyer: Surgical Science (OM:SUS:$7.20)
Surgical Science is a Swedish supplier of virtual reality simulators for medical training. Their training systems for laparoscopy and endoscopy are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors. "
target: SenseGraphics
SenseGraphics is a Sweden-based medical simulator software developer. SenseGraphics develops next generation medical simulators for a wide range of surgical procedures. Their simulators combine the latest technologies to provide surgeons with an experience that is as close to reality as possible.
price ($mm)
$32
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2018 via GlobeNewswire

Globus Medical, acquired Surgimap

synopsis: Globus Medical, Inc., a leading musculoskeletal solutions company, announced the acquisition of Nemaris Inc., a privately held company that markets and develops Surgimap®, a leading surgical planning software platform.
buyer: Globus Medical (GMED:$675.57)
Globus Medical, Inc. is a leading medical device manufacturer and is driving significant technological advancements across a complete suite of spinal products. "
target: Surgimap
Nemaris Inc. is a privately held company that markets and develops Surgimap®, a leading surgical planning software platform. Surgimap® allows healthcare professionals to simulate potential surgical outcomes and share medical imaging globally to improve procedural workflow and patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/19/2017 via Company Press Release

JSR Corporation, will acquire Lexi Co., Ltd.

synopsis: JSR Corporation agreed to acquire Lexi Co., Ltd., a medical 3D software company. Lexi Co., Ltd. develops 3D medical pre-operative planning software. Its ZedHip, ZedKnee and JIGEN software can create 3D models of the bone using CT data.
buyer: JSR Corporation (TSE:4185:$3,499.68)
JSR Corporation, based in Japan, was established in 1957 for domestic production of synthetic rubbers. Since then, JSR has continuously expanded its business to emulsions, plastics and other materials for the semiconductor, flat panel display, and optical materials fields. "
target: Lexi Co., Ltd.
Lexi is a Japanese company that develops 3D medical pre-operative planning software. Its ZedHip, ZedKnee and JIGEN software can create 3D models of the bone using CT data. Users can perform surgical simulations (such as positioning of implants, calculation of parameters, etc.) in simple steps.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2014 via GlobeNewswire

3D Systems Corporation, acquired Simbionix USA Corporation

synopsis: 3D Systems announced that it completed the acquisition of Simbionix, the global leader in 3D virtual reality surgical simulation and training for $120 million in cash. Simbionix USA Corporation is the world's leading provider of 3D simulation and training products for medical professionals and the healthcare industry.
buyer: 3D Systems Corporation (DDD:$617.50)
3D Systems is a leading provider of 3D printing centric design-to-manufacturing solutions including 3D printers, print materials and cloud sourced on-demand custom parts for professionals and consumers alike in materials including plastics, metals, ceramics and edibles. "
target: Simbionix USA Corporation
Simbionix USA Corporation is the world's leading provider of 3D simulation and training products for medical professionals and the healthcare industry. The company is committed to delivering the highest quality products, advancing clinical performance and optimizing procedural outcomes.
price ($mm)
$120
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/9/2019 via PE Hub

Micromed SpA, acquired OSG bvba

synopsis: Micromed, an Italian medical device company, has acquired OSG BVBA, a Belgium-based sleep diagnostics software company strongly positioned in sleep neuromonitoring and clinical neurophysiology. With the acquisition, Micromed will gain direct access to the Benelux market, thanks to OSG’s strong position in the area.
buyer parent: ArchiMed
buyer: Micromed SpA
Micromed is an Italian medical device company delivering solutions in Neurophysiology worldwide. Partnering with hospitals, sleep labs, and research centers on a global scale, Micromed manufactures and markets neurodiagnostic hardware and software to neurologists, clinicians and researchers. "
target: OSG bvba
OSG is a Belgian developer of software products for Sleep Research and Brain Research. With their products BrainRT and SleeptRT, OSG is highly regarded in sleep neuromonitoring and clinical neurophysiology with advanced capabilities in AI as it relates to sleep scoring and data interpretation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/10/2014 via PR Newswire

Alphaeon Corporation, acquired TouchMD

synopsis: ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired TouchMD. TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates.
buyer parent: Strathspey Crown
buyer: Alphaeon Corporation
Alphaeon Corporation is a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. "
target: TouchMD
TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates. They offer product lines in Plastics, OBGYN, Dermatology, and Orthopedics.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/27/2016 via BNC Analysis

Venaxis, Inc., will acquire Strand Life Sciences

synopsis: Venaxis, a developer of an in vitro diagnostic test for acute appendicitis, is to acquire Strand Life Sciences, a cancer genomics firm. Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
buyer: Venaxis, Inc. (BIOP:$0.01)
Venaxis is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic test, the APPY1™ Test, which is designed to aid in the identification of patients at low risk for acute appendicitis. "
target: Strand Life Sciences
Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/20/2019 via BNC Analysis

Circle Cardiovascular Imaging Inc., acquired Corstem

synopsis: Circle Cardiovascular Imaging, a Canadian developer of analytical software for the cardiac imaging community, has acquired Corstem, a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables better, safer, and faster care decision.​
buyer: Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging is a Canadian developer of analytical software for the cardiac imaging community. Circle's product suite, civ42, is engineered for use in cardiac imaging and has been designed specifically to facilitate efficient quantitative evaluation of cardiac imaging studies. "
target: Corstem
Corstem is a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables a whole new level of efficiency and automation for diagnosis aid to achieve better, safer, and faster care decision.​
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/6/2018 via BNC Analysis

Philips Electronics NV, will acquire EPD Solutions Ltd.

synopsis: Royal Philips, a global leader in health technology, will acquire EPD Solutions from the Hobart Group, an international portfolio of medical device companies. EPD specializes in making cardiac imaging and navigation systems that help electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$23,759.43)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target parent: Hobart Group (Medical Device)
target: EPD Solutions Ltd.
EPD Solutions (EPD) is dedicated to improving the efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias. EPD's cardiac imaging and navigation system helps electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
price ($mm)
$292
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/13/2015 via BusinessWire

Toshiba Medical Systems Corporation, acquired Olea Medical

synopsis: Olea Medical SA, a company that designs and markets innovative medical imaging applications, has been acquired by Toshiba Medical Systems Corporation, a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions.
buyer parent: Toshiba
buyer: Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. "
target: Olea Medical
Olea Medical™ designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. They are based in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2021 via GlobeNewswire

SeaSpine, acquired 7D Surgical

synopsis: SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, has acquired 7D Surgical, a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
buyer: SeaSpine (SPNE:$160.19)
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. "
target: 7D Surgical
7D Surgical is a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
price ($mm)
$110
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2020 via BusinessWire

RapidAI, acquired Endovantage, LLC

synopsis: RapidAI, the worldwide leader in advanced imaging for stroke, announced the acquisition of EndoVantage, developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
buyer: RapidAI
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS*. "
target: Endovantage, LLC
EndoVantage is the developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2014 via PR Newswire

Varian Medical Systems, Inc., purchased Radiation Simulation Software from Transpire, Inc.

synopsis: Varian Medical Systems, Inc., announced it has acquired certain assets of Transpire, Inc., including the Acuros® dose calculation software that has been integrated into Varian's market-leading BrachyVision™ and Eclipse™ treatment planning software products. The acquisition also covers Transpire's Attila™ software.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. "
seller: Transpire, Inc.
Transpire develops advanced simulation software products that accurately and rapidly predict the macroscopic behavior of radiation. Their software includes the Attila™ software, used in industries where radiation effects play a role in product performance, and the Acuros® dose calculation software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2018 via Company Press Release

Varian Medical Systems, Inc., acquired Noona Healthcare

synopsis: Varian, a leader in developing and delivering cancer care solutions, has announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs).
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Varian has pioneered developments in radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. "
target: Noona Healthcare
Noona Healthcare is the developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The Noona patient software app lets clinics capture PROs and communicate directly with patients. They are based in Finland.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/5/2018 via Company Press Release

Varian Medical Systems, Inc., acquired Mobius Medical Systems, LP

synopsis: Varian, a leader in developing and delivering cancer care solutions, has acquired Mobius Medical Systems, a leader in radiation oncology Quality Assurance (QA) software. The Mobius QA software is in use at over 1000 sites to ensure patients receive high-quality care. Mobius3D is a 3D dose verification and IMRT/VMAT treatment delivery QA system.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Varian has pioneered developments in radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. "
target: Mobius Medical Systems, LP
Mobius Medical Systems is a leader in radiation oncology Quality Assurance (QA) software. The Mobius QA software is in use at over 1000 sites worldwide to ensure patients receive high-quality care. Mobius3D is a 3D dose verification and IMRT/VMAT treatment delivery QA system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2014 via PR Newswire

Varian Medical Systems, Inc., purchased Radiation Simulation Software from Transpire, Inc.

synopsis: Varian Medical Systems, Inc., announced it has acquired certain assets of Transpire, Inc., including the Acuros® dose calculation software that has been integrated into Varian's market-leading BrachyVision™ and Eclipse™ treatment planning software products. The acquisition also covers Transpire's Attila™ software.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. "
seller: Transpire, Inc.
Transpire develops advanced simulation software products that accurately and rapidly predict the macroscopic behavior of radiation. Their software includes the Attila™ software, used in industries where radiation effects play a role in product performance, and the Acuros® dose calculation software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2014 via MediaGuardian.

Varian Medical Systems, Inc., purchased Software Platform from Velocity Medical Solutions, LLC

synopsis: Varian Medical Systems announced it has completed the acquisition of certain assets of Velocity Medical Solutions, a developer of specialized software for cancer clinics. The acquisition includes software that enables clinicians to aggregate unstructured treatment and imaging data from diverse systems to make more informed treatment decisions.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. "
seller: Velocity Medical Solutions, LLC
Velocity Medical Solutions is a developer of specialized software for cancer clinics. Their Software Platform enables clinicians to aggregate unstructured treatment and imaging data from diverse systems to make more informed treatment decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/5/2012 via PR Newswire

Varian Medical Systems, Inc., will acquire InfiMed, Inc.

synopsis: Varian Medical Systems, Inc., announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. "
target: InfiMed, Inc.
Since 1983, InfiMed, Inc. has been a developer of digital medical acquisition, image processing, and sensor solutions. These systems are used in hospital Cath Labs, X-ray departments, imaging centers, and trauma centers worldwide.
price ($mm)
$15
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.0x
EV / EBITDA
closed 6/25/2009 via PR Newswire

Varian Medical Systems, acquired IKOEmed, LLC.

synopsis: Varian Medical Systems, Inc., announced that it has acquired the assets of Houston-based IKOEmed and IKOEtech, privately-owned suppliers of software used in the planning of radiotherapy and radiosurgery treatments.
buyer: Varian Medical Systems (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. "
target: IKOEmed, LLC.
IKOEmed is a privately-owned supplier of software used in the planning of radiotherapy and radiosurgery treatments.
price ($mm)
$2.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2014 via PR Newswire

Varian Medical Systems, Inc., purchased Radiation Simulation Software from Transpire, Inc.

synopsis: Varian Medical Systems, Inc., announced it has acquired certain assets of Transpire, Inc., including the Acuros® dose calculation software that has been integrated into Varian's market-leading BrachyVision™ and Eclipse™ treatment planning software products. The acquisition also covers Transpire's Attila™ software.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. "
seller: Transpire, Inc.
Transpire develops advanced simulation software products that accurately and rapidly predict the macroscopic behavior of radiation. Their software includes the Attila™ software, used in industries where radiation effects play a role in product performance, and the Acuros® dose calculation software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/5/2019 via PR Newswire

Volpara Solutions, will acquire MRS Systems

synopsis: New Zealand-based Volpara, a provider of breast imaging analytics products for improving the early detection of breast cancer, will acquire MRS Systems, Inc. MRS provides comprehensive patient tracking, communication, and a radiology reporting platform for sub-specialty radiology applications including breast and lung imaging.
buyer: Volpara Solutions (ASX:VHT:$3.29)
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT. "
target: MRS Systems
MRS Systems, Inc. tracks and reports on breast and lung cancer screening and imaging reports, among others. Users interact with MRS's software to document patient history, risk factors, and the findings of advanced imaging of patients using X-rays, MRI, CT, Ultrasound and other modalities.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/14/2016 via PR Web

Inspirata, Inc., acquired Precision Medicine Network, Inc.

synopsis: Cancer diagnostics and digital pathology workflow solution provider Inspirata, Inc. announced that it has acquired the assets of Boston-based Precision Medicine Network™, Inc. This includes “Crosswalk Insight: Oncology” (Crosswalk), a precision medicine knowledge visualization and decision support platform.
buyer: Inspirata, Inc.
Inspirata™, Inc. provides a cancer diagnostics solution that digitizes and automates the entire pathology workflow using a unique, “solution as a service” delivery model. "
target: Precision Medicine Network, Inc.
Precision Medicine Network's “Crosswalk Insight: Oncology” (Crosswalk) is a precision medicine knowledge visualization and decision support platform. The company’s mission is to provide “Fluency in the language of Precision Medicine™” as a basis of connecting providers, patients and payers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
on offer 10/13/2015 via

Progenics Pharmaceuticals, offer to acquire EXINI Diagnostics

synopsis: Progenics Pharmaceuticals announced its offer to acquire EXINI Diagnostics, a leader in the development software solutions for medical decision support based on advanced image analysis. The deal provides Progenics with sophisticated software and other technologies that help physicians and patients visualize, understand, target and treat cancer.
buyer: Progenics Pharmaceuticals (PGNX:$43.27)
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer. "
target parent: Avanza Bank Holding
target: EXINI Diagnostics
EXINI develops and provides software for automated image analysis, increasing accuracy and improving clinical efficiency when treating prostate cancer and other diseases. Their image analysis technology combines the power of artificial neural networks, expert medical knowledge and large databases.
price ($mm)[EV]
$7.12 [$6.63]
rev ($mm)
$2
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 9/6/2011 via BusinessWire

ION Solutions, acquired IntrinsiQ, LLC

synopsis: AmerisourceBergen Corporation announced that it has completed the acquisition of IntrinsiQ, LLC, a leading provider of informatics solutions that help community oncologists make treatment decisions for their patients. IntrinsiQ will become part of ION Solutions, which is a unit of AmerisourceBergen Specialty Group.
buyer parent: AmerisourceBergen Corporation
buyer: ION Solutions
A part of AmerisourceBergen Specialty Group, ION Solutions provides technologies, resources and expertise to community-based oncologists to help improve clinical and operational management. ION Solutions represents more than half of the community-based oncology market in the US. "
target parent: Kohlberg Kravis Roberts & Co.
target: IntrinsiQ, LLC
IntrinsiQ improves the quality and understanding of cancer care, at every step. Its flagship clinical software, IntelliDose®, tracks and manages complex chemotherapy workflows across busy practices.
price ($mm)
$35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2006 via BusinessWire

Accel-KKR, acquired IntrinsiQ

synopsis: Accel-KKR, a technology-focused private equity investment firm, announced its acquisition of a majority equity stake in IntrinsiQ, the national leader in medical oncology care software and the only source for automated longitudinal data on trends in cancer drug usage. Financial terms of the transaction were not disclosed
buyer: Accel-KKR
Accel-KKR is a technology-focused private equity firm with over $1 billion in assets under management. The firm invests primarily in software and IT-enabled businesses well positioned for top-line and bottom-line growth. "
target: IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details for nearly 20,000 unique patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
cancelled 6/2/2011 via

Monar International Inc., cancelled merger with Integrated Clinical Care Corporation

synopsis: Monar International Inc. has recently entered into a Memorandum of Understanding for the acquisition of up to 100% of the shares of Integrated Clinical Care Corporation (ICC). ICC’s proprietary IT system is the result of a unique collaboration between major care centers, leading healthcare service companies and medical informatics specialists.
buyer: Monar International Inc. (MNAI:$0.00)
Monar International Inc., a development stage company, intends to develop a Web site that would offer the public traditional style Chinese furniture adapted to modern needs for Asian ethnic and high end markets in North America. "
target: Integrated Clinical Care Corporation
Integrated Clinical Care offers to medical practices usable work flow solutions that include advanced support systems at the point-of-care in the field of medical / clinical services with a special emphasis on the fast evolving practice of oncology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/27/2018 via PR Newswire

Elekta AB, acquired ACUMYN Inc.

synopsis: Elekta, the leading innovator of equipment and software used to improve and save lives, announced that it has acquired Acumyn, the Canadian quality assurance (QA) company. AQUA, Acumyn's Quality Management System, is a comprehensive software platform that coordinates and centralizes all of the QA tests needed.
buyer: Elekta AB (OM:EKTA B:$1,523.59)
Based in Sweden, Elekta AB is the leading innovator of equipment and software used to improve and save the lives of people with cancer and brain disorders. Elekta treatment solutions and oncology informatics are designed to enhance the delivery of treatment. "
target: ACUMYN Inc.
Acumyn, a medical technology company, created AQUA, a Quality Assurance software that ensures radiotherapy and medical imaging devices will perform reliably to deliver the best possible care to patients. Acumyn is known for their integrated Quality Management System, AQUA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2020 via Company Press Release

Medtronic, Inc., acquired Digital Surgery

synopsis: Medtronic, the global leader in medical technology, announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic is among the world’s largest medical technology, services and solutions companies, alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients. "
target: Digital Surgery
Headquartered in London, England, Digital Surgery’s mission is to digitize surgical protocols using cutting-edge computing and to support the delivery of consistent, data-driven and evidence-based surgical care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/8/2016 via PR Newswire

IntelliCentrics, acquired Xray Trax LLC

synopsis: IntelliCentrics, a leading provider of healthcare management and compliance services, has acquired XrayTrax, the leader in radiation monitoring for a large and important group of individuals whose occupation requires them to visit multiple healthcare locations thereby extending IntelliCentrics' SEC³URE community.
buyer parent: VTC Electronics
buyer: IntelliCentrics
IntelliCentrics is a leading provider of managed services that help healthcare leaders execute and maintain compliance programs, including radiation exposure management, resulting in safer and more SEC³URE facilities. "
target: Xray Trax LLC
XrayTrax provides cumulative radiation monitoring and education for Healthcare Industry Representatives, ensuring compliance with current state and federal guidelines. XrayTrax is the only program currently available to assist facilities with radiation exposure of their vendors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/15/2018 via Company Press Release

Roche Ltd, will acquire Flatiron Health

synopsis: Flatiron Health, Inc. announced that it has signed a definitive agreement under which Roche will acquire all shares of Flatiron Health. Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Flatiron Health
Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. The Flatiron platform enables cancer researchers and care providers to learn from the experience of every patient.
price ($mm)
$1,900*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2014 via Company Press Release

Flatiron Health, will acquire Altos Solutions

synopsis: Flatiron Health, developers of the OncologyCloud™ platform, has reached an agreement to acquire Altos Solutions, Inc., a leading web-based oncology software company and developer of the OncoEMR™ electronic medical record (EMR) system.
buyer: Flatiron Health
Flatiron Health is a health care technology company and operator of the OncologyCloud platform. Integrating across the entire clinical data spectrum, it allows cancer care providers and life science companies to gain deep business and clinical intelligence through its web-based platform. "
target: Altos Solutions
Altos Solutions, Inc. is the pioneer in secure web-based oncology-specific software applications; focusing on intuitive electronic medical records, practice management with integrated medical billing, real-time comparative analytics, and patient and provider portals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/5/2018 via Company Press Release

Varian Medical Systems, Inc., acquired Mobius Medical Systems, LP

synopsis: Varian, a leader in developing and delivering cancer care solutions, has acquired Mobius Medical Systems, a leader in radiation oncology Quality Assurance (QA) software. The Mobius QA software is in use at over 1000 sites to ensure patients receive high-quality care. Mobius3D is a 3D dose verification and IMRT/VMAT treatment delivery QA system.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Varian has pioneered developments in radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. "
target: Mobius Medical Systems, LP
Mobius Medical Systems is a leader in radiation oncology Quality Assurance (QA) software. The Mobius QA software is in use at over 1000 sites worldwide to ensure patients receive high-quality care. Mobius3D is a 3D dose verification and IMRT/VMAT treatment delivery QA system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2012 via GlobeNewswire

Mediware Information Systems, Inc., purchased Cyto Management System from Cobbler ICT Services BV

synopsis: Mediware® Information Systems, Inc. announced that it has finalized the acquisition of the Cyto Management System (CMS) from Cobbler ICT Services BV. The CMS software is a comprehensive chemotherapy management software solution deployed in Holland and Belgium.
buyer: Mediware Information Systems, Inc.
Mediware Information Systems delivers interoperable best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. "
seller: Cobbler ICT Services BV
Cobbler ICT Services BV owns Cyto Management System (CMS), a comprehensive chemotherapy management software solution deployed in Holland and Belgium. The CMS software is a comprehensive 'closed loop' solution for managing chemotherapy treatments.
price ($mm)
$2.23
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2020 via BusinessWire

Wenzel Spine, Inc., acquired Statera Spine, Inc.

synopsis: Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, has acquired Statera Spine, a pre-operative diagnostics and quantitative data software solution that improves treatment decisions for spine patients.
buyer: Wenzel Spine, Inc.
Wenzel Spine is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. Wenzel Spine is focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. "
target: Statera Spine, Inc.
Statera Spine is a software-enabled spine imaging analytics company providing solutions that improve care for patients with chronic and acute spine issues. The company offers two solutions for spinal treatment, Profile-ESP (Expanded Spine Parameters Report) and VMA (Vertebral Motion Analysis).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/28/2017 via GlobeNewswire

Medasys, acquired Netika SAS

synopsis: Medasys, a company that offers software solutions to the Patient Records, care provision, Biology and Medical Imaging departments of private and public sector healthcare institutions, has acquired Netika, a company that specializes in software for quality assurance and management of laboratory information systems.
buyer parent: Ardian
buyer: Medasys (ENXTPA:MED:$38.05)
Medasys has been supporting the performance, quality and innovation of private and public healthcare institutions for almost 30 years, providing them with proven solutions in the Patient Records, care provision, Biology and Medical Imaging departments. "
target: Netika SAS
Netika is a French IT services provider, based in Strasbourg, dedicated to the medical sector since 2000. With more than 2,200 health institutions that trust it, Netika is a key player for medical laboratories, but is opening to new medical domains such as medical imaging and radiotherapy.
price ($mm)
$11
rev ($mm)
$7
EBITDA ($mm)
$1
EV / rev
1.6x
EV / EBITDA
9.8x
announced 7/18/2017 via BNC Analysis

Philips Electronics NV, will acquire TomTec Imaging Systems GmbH

synopsis: Philips Electronics NV announced that it has signed an agreement to acquire TomTec Imaging Systems GmbH, a provider of intelligent image analysis software, especially for diagnostic ultrasound. Tomtec's products and services support clinicians to increase efficiency and diagnostic quality through automated and reproducible measurements.
buyer: Philips Electronics NV (ENXTAM:PHIA:$23,759.43)
Royal Philips of the Netherlands is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target: TomTec Imaging Systems GmbH
Headquartered in Munich, Germany, TomTec Imaging Systems is a worldwide leader for medical image software solutions. Their products encompass a wide range of 2D and 3D/4D technology for visualization, automated analysis, quantification, reporting and image management.
price ($mm)
rev ($mm)
$11
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 3/8/2017 via BusinessWire

Envision Healthcare Holdings, Inc., will acquire Imaging Advantage LLC

synopsis: Envision Healthcare has entered into a definitive agreement to acquire Imaging Advantage LLC, a provider of comprehensive radiology services including hospital-based, outpatient and remote-reading services. Imaging Advantage deploys an innovative and scalable cloud-based technology to optimize provider utilization and efficiency of radiologists.
buyer: Envision Healthcare Holdings, Inc. (EVHC:$3,696.00)
Envision Healthcare Corporation is a leading provider of physician-led services, ambulatory surgery services, post-acute care and medical transportation. Physician-led services encompass providers at more than 780 hospitals in 45 states. "
target: Imaging Advantage LLC
Imaging Advantage is a leading provider of evidence-based, end-to-end technology enhanced radiology solutions to hospitals across the country. Imaging Advantage provides technology and practice management solutions to a number of prominent healthcare systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2013 via Company Press Release

EMIS Group PLC, acquired Digital Healthcare Limited

synopsis: EMIS Group, the UK’s leading supplier of healthcare software to GPs and a major software supplier to high street pharmacies has acquired Digital Healthcare. Digital Healthcare's principal area of business is providing solutions and services to manage and support systematic population-based retinal screening programmes.
buyer: EMIS Group PLC (AIM:EMIS:$216.76)
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems. "
target: Digital Healthcare Limited
Digital Healthcare Limited provides image management and storage solutions for the ophthalmology sector. The company’s products include OptoMize, a retinopathy screening solution; OcuLab, an ophthalmology image management system; and Retasure, a diabetic retinal risk assessment system.
price ($mm)
$4.75
rev ($mm)
$5
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 2/28/2013 via BNC Analysis

Novacyt Société Anonyme, acquired CCITI

synopsis: Novacyt acquired the assets of Centre of Competence in International Tele-imaging (CCITI), specializing in digital pathology. The integration of active CCITI and its software suite for digital pathology provide an additional service to the diagnostics software module developed by Novacyt cell recognition.
buyer: Novacyt Société Anonyme
Novacyt Société Anonyme develops and markets liquid-based cytology solutions. It provides liquid cytology vials and sedimentation systems; Novastic, a liquid to optimize adherence of cells onto the glass slide; and NovaPrep processor systems for mass screening and personalized diagnosis. "
target: CCITI
CCITI (international competency center in Télé Imaging) is a software editor and consultant for healthcare and Life sciences. They provide innovative solutions based on full web solutions, digital slides and multimedia imaging along with knowledge management tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Radiation Simulation Software


read more

Transpire, Inc.

Cadens Medical Imaging

THERENVA

Neomedix Corporation

Definiens

OrthoView

SenseGraphics

MST Medical Surgery Technologies Ltd.

Surgimap

Lexi Co., Ltd.

Simbionix USA Corporation

OSG bvba

TouchMD

Strand Life Sciences

Corstem

EPD Solutions Ltd.

imorphics

Olea Medical

7D Surgical

Endovantage, LLC

read more

Transpire, Inc.

read more

Noona Healthcare

Mobius Medical Systems, LP

Transpire, Inc.

Velocity Medical Solutions, LLC

InfiMed, Inc.

IKOEmed, LLC.

read more

Transpire, Inc.

MRS Systems

Precision Medicine Network, Inc.

EXINI Diagnostics

IntrinsiQ, LLC

IntrinsiQ

Integrated Clinical Care Corporation

ACUMYN Inc.

Digital Surgery

Xray Trax LLC

Flatiron Health

Altos Solutions

Mobius Medical Systems, LP

Cobbler ICT Services BV

Statera Spine, Inc.

Netika SAS

TomTec Imaging Systems GmbH

Imaging Advantage LLC

Digital Healthcare Limited

CCITI

Geography
Matching Companies
Ticker: OM:EKTA B
 
 
 
 
 
 
 
 
Elekta AB
Elekta AB
Elekta is pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops state-of-the-art tools and treatment-planning systems for radiation therapy, as well as workflow-enhancing software systems across the spectrum of cancer care.
year
2020
rev ($mm)
$1,523.59
EBITDA ($mm)
$230.61
EBIT ($mm)
$200.20
Net Income ($mm)
$125.79
Employees
4000
  • drill down
  • watch
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: GS:MTLS
 
 
 
 
 
 
 
 
Materialise Dental N.V.
Materialise Dental N.V.
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis.
year
2014
rev ($mm)
$86.16
EBITDA ($mm)
$5.18
EBIT ($mm)
$0.35
Net Income ($mm)
$2.18
Employees
958
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: KOSDAQ:A263700
 
 
 
 
 
 
 
 
Carelabs Co., Ltd.
Carelabs Co., Ltd.
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions.
year
2019
rev ($mm)
$49.51
EBITDA ($mm)
$4.38
EBIT ($mm)
$3.14
Net Income ($mm)
$1.79
Employees
0
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: ICAD
 
 
 
 
 
 
 
 
iCAD, Inc.
iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster. iCAD offers a range of computer aided detection (CAD) solutions to support rapid detection of breast, prostate and colorectal cancers.
year
2015
rev ($mm)
$47.24
EBITDA ($mm)
$5.53
EBIT ($mm)
$1.33
Net Income ($mm)
Employees
143
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,552.99
EBITDA ($mm)
$1,247.29
EBIT ($mm)
$792.06
Net Income ($mm)
$792.91
Employees
27400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CPSI
 
 
 
 
 
 
 
 
CPSI
CPSI
CPSI is a leading provider of healthcare solutions and services for community hospitals, their clinics and post-acute care facilities. Founded in 1979, CPSI is the parent of three companies – Evident, LLC, American HealthTech, Inc. and TruBridge, LLC.
year
2021
rev ($mm)
$262.74
EBITDA ($mm)
$33.37
EBIT ($mm)
$19.84
Net Income ($mm)
$14.30
Employees
2000
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: MASI
 
 
 
 
 
 
 
 
Masimo
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions.
year
2019
rev ($mm)
$913.46
EBITDA ($mm)
$234.73
EBIT ($mm)
$213.99
Net Income ($mm)
$190.23
Employees
1500
  • drill down
  • watch
Ticker: ASX:PGC
 
 
 
 
 
 
 
 
Paragon Care
Paragon Care
Paragon Care is a company focused on Hospital & Healthcare services and has progressively acquired businesses in the healthcare sector. It is a leading provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.
year
2018
rev ($mm)
$98.79
EBITDA ($mm)
$9.27
EBIT ($mm)
$8.09
Net Income ($mm)
$7.91
Employees
508
  • drill down
  • watch
Ticker: ENXTPA:ALVMG
 
 
 
 
 
 
 
 
Visiomed Group SA
Visiomed Group SA
Founded in 2007, Visiomed Group is a company that specializes in next-generation medical electronics. The laboratory develops and markets innovative healthcare products in the promising areas of self-diagnosis for medical use and well-being.
year
2017
rev ($mm)
$11.54
EBITDA ($mm)
($16.87)
EBIT ($mm)
($17.34)
Net Income ($mm)
Employees
102
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: ILMN
 
 
 
 
 
 
 
 
Illumina, Inc.
Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.
year
2020
rev ($mm)
$3,556.00
EBITDA ($mm)
$1,198.00
EBIT ($mm)
$1,013.00
Net Income ($mm)
$942.00
Employees
7700
  • drill down
  • watch
Ticker: BRKR
 
 
 
 
 
 
 
 
Bruker Corporation
Bruker Corporation
Bruker Corporation is a global manufacturer of high-end analytical instruments used within the academic & government, pharma/biotech, clinical diagnostic, and industrial markets. It operates in the life science tools and diagnostic indsutry.
year
2018
rev ($mm)
$1,925.30
EBITDA ($mm)
$347.10
EBIT ($mm)
$279.00
Net Income ($mm)
$183.50
Employees
6870
  • drill down
  • watch
Ticker: XRAY
 
 
 
 
 
 
 
 
Dentsply Sirona
Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide.
year
2017
rev ($mm)
$3,993.40
EBITDA ($mm)
$830.20
EBIT ($mm)
$513.80
Net Income ($mm)
Employees
16100
  • drill down
  • watch
Ticker: ISRG
 
 
 
 
 
 
 
 
Intuitive Surgical
Intuitive Surgical
Intuitive, headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, they believe that minimally invasive care is life-enhancing care.
year
2019
rev ($mm)
$4,478.50
EBITDA ($mm)
$1,575.00
EBIT ($mm)
$1,375.30
Net Income ($mm)
$1,379.30
Employees
7326
  • drill down
  • watch
Ticker: TASE:MDGS
 
 
 
 
 
 
 
 
Medigus
Medigus
Medigus is an Israeli medical device company. Medigus specializes in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Their MUSE system is a comprehensive endoscopic device for treating GERD (gastroesophageal reflux disease).
year
2020
rev ($mm)
$0.20
EBITDA ($mm)
($5.53)
EBIT ($mm)
($5.64)
Net Income ($mm)
Employees
20
  • drill down
  • watch
Ticker: HLSE:REG1V
 
 
 
 
 
 
 
 
Revenio Group
Revenio Group
Revenio Group is a global leader in ophthalmic diagnostics and ophthalmic devices. Revenio's eye diagnostics solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. Their tools are used to detect and diagnose glaucoma.
year
2020
rev ($mm)
$72.76
EBITDA ($mm)
$23.80
EBIT ($mm)
$21.48
Net Income ($mm)
$15.86
Employees
143
  • drill down
  • watch
Ticker: OM:EKTA B
 
 
 
 
 
 
 
 
Elekta AB
Elekta AB
Elekta is pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops state-of-the-art tools and treatment-planning systems for radiation therapy, as well as workflow-enhancing software systems across the spectrum of cancer care.
year
2020
rev ($mm)
$1,523.59
EBITDA ($mm)
$230.61
EBIT ($mm)
$200.20
Net Income ($mm)
$125.79
Employees
4000
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: RMD
 
 
 
 
 
 
 
 
ResMed
ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases.
year
2019
rev ($mm)
$2,784.41
EBITDA ($mm)
$858.38
EBIT ($mm)
$696.96
Net Income ($mm)
$454.92
Employees
7240
  • drill down
  • watch